KRONOX vs ROSSARI: Stock Comparison
ROSSARI BIOTECH is the larger company by market capitalisation. KRONOX shows a higher ROE, a higher dividend yield and lower leverage, while ROSSARI BIOTECH shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
KRONOX leads 6; ROSSARI leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | KRONOX | ROSSARI |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | KRONOX | ROSSARI |
|---|---|---|
| Live Price | ₹186.14 | ₹407.6 |
| Day Change | -9.36% | -0.2% |
| Volume | 10.27 L | 49,434 |
| 52-Week High | ₹223.42 | ₹656.05 |
| 52-Week Low | ₹96 | ₹375 |
| Distance from 52W High | -16.69% | -37.87% |
Valuation
| Metric | KRONOX | ROSSARI |
|---|---|---|
| Market Cap | ₹726 Cr | ₹2,255 Cr |
| P/E Ratio | 25.42x | 14.76x |
| P/B Ratio | 6.25x | 1.6x |
| EPS | ₹1.97 | ₹7.02 |
| Book Value | ₹31.3 | ₹240.7 |
| Dividend Yield | 0.26% | 0.12% |
Growth
| Metric | KRONOX | ROSSARI |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 18.2% |
| EPS Growth (TTM YoY) | 26.7% | 33.5% |
| Qtr Sales Growth | 0% | 0.05% |
| Qtr Profit Growth | 0% | 10.86% |
Profitability & Leverage
| Metric | KRONOX | ROSSARI |
|---|---|---|
| ROE | 23.72% | 11.72% |
| ROCE | 23.66% | 11.79% |
| Net Margin | 27.21% | 6.14% |
| Operating Margin | 36.85% | 11.67% |
| Debt to Equity | 0.01x | 0.1x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | KRONOX | ROSSARI |
|---|---|---|
| Promoter Holding | 64.26%▼ 9.95 pp | 63.63% |
| FII Holding | 0.1%▲ 0.06 pp | 1.84%▼ 0.18 pp |
| DII Holding | 2.54%▲ 0.47 pp | 14.19%▼ 0.45 pp |
| Public Holding | 33.1%▲ 9.43 pp | 15.83%▲ 0.63 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KRONOX and ROSSARI BIOTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.